These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 21481495

  • 1. [Short-term results of treatment with 131I in patients with multinodular goiter: effect of the associated degree of hyperthyroidism and other variables].
    Boj Carceller D, Liévano Segundo P, Navarro Beltrán P, Sanz París A, de Castro Hernández P, Monreal Villanueva M, Abós Olivares D.
    Rev Esp Med Nucl; 2011; 30(3):156-61. PubMed ID: 21481495
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R, Rubio IG, Tomimori EK, Camargo RY, Knobel M, Medeiros-Neto G.
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [Abstract] [Full Text] [Related]

  • 4. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
    Abós MD, Banzo J, Razola P, García F, Prats E.
    Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
    [Abstract] [Full Text] [Related]

  • 5. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B, Faber J, Veje A, Hegedüs L, Hansen JM.
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA, Daykin J, Holder R, Sheppard MC.
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [Abstract] [Full Text] [Related]

  • 11. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
    Ruchała M, Sowiński J, Dolata M, Junik R, Gembicki M, Skiba A.
    Nucl Med Rev Cent East Eur; 2005 Mar; 8(1):28-32. PubMed ID: 15977144
    [Abstract] [Full Text] [Related]

  • 12. Long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy.
    Khanna CM, Magdam M, Ravishankar L, Dham DN, Chugh P.
    J Assoc Physicians India; 1995 Oct; 43(10):685-8. PubMed ID: 8773004
    [Abstract] [Full Text] [Related]

  • 13. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA, Christ-Crain M, Eckard B, Schindler C, Nitzsche EU, Müller-Brand J, Müller B.
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [Abstract] [Full Text] [Related]

  • 14. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy.
    Kahraman D, Keller C, Schneider C, Eschner W, Sudbrock F, Schmidt M, Schicha H, Dietlein M, Kobe C.
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):297-303. PubMed ID: 21854403
    [Abstract] [Full Text] [Related]

  • 15. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN, Abdelrazek S, Szumowski P, Rogowski F, Sykała M, Kostecki J, Kociura-Sawicka A, Jurgilewicz D, Myśliwiec J.
    Nucl Med Rev Cent East Eur; 2016 Feb; 19(1):3-11. PubMed ID: 26841373
    [Abstract] [Full Text] [Related]

  • 16. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
    Erem C, Kandemir N, Hacihasanoglu A, Ersöz HO, Ukinc K, Kocak M.
    Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
    [Abstract] [Full Text] [Related]

  • 17. Outcome of treatment of hyperthyroidism.
    Bringmann IM, van Leeuwen BL, Hennemann G, Beckett GJ, Toft AD.
    J Endocrinol Invest; 1999 Apr; 22(4):250-6. PubMed ID: 10342357
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Study of factors that influence the outcome of 131I treatment in hyperthyroidism secondary to nodular goitre.
    Tabuenca-Dopico O, Boente-Varela R, Lamas-Ferreiro JL.
    Rev Esp Med Nucl Imagen Mol; 2017 Apr; 36(6):356-361. PubMed ID: 28619420
    [Abstract] [Full Text] [Related]

  • 20. Post-ablative hypothyroidism.
    Yaqub A, Choudhry MI, Wheaton J, Gress T.
    W V Med J; 2011 Apr; 107(2):37-40. PubMed ID: 21476476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.